• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Analogic dissident shareholders’ hand-picked board member drops out

Analogic dissident shareholders’ hand-picked board member drops out

January 28, 2010 By MassDevice staff

Officials at Analogic Corp. (NSDQ:ALOG) said Dr. Burton Drayer took his name out of the running for a board seat at the Peabody, Mass.-based imaging device maker.

Drayer, the executive vice president for risk and chair of the radiology department at the New York’s Mount Sinai Medical Center, was handpicked by Ramius LLC, a New York-based hedge fund and activist investor group that agitated for changes after Analogic posted dismal results for fiscal 2009. Company officials said Drayer came to his decision after consulting with his employer about sitting on outside boards.

Ramius owns about 5 percent of Analogic’s outstanding shares. In December, Analogic officials announced that the company and Ramius managers reached a settlement to avoid a potential proxy fight over the direction of the company.

The settlement called for Analogic to nominate Drayer to its board of directors. The company expected Drayer to serve on its nominating and corporate governance committee. The deal also called for Analogic to ask shareholders to approve an expansion of its board from 10 to 11 members, with a new independent director taking a seat by March 31, 2010. It also called for the company to issue a “Financial Pathway Statement,” detailing its plans to reach “double-digit operating margins by fiscal year 2012.”

Despite Drayer’s removal of himself from consideration, the former dissident investors will still have a chance to imprint their vision onto the company. According to the settlement, if Drayer leaves the board prior to the 2011 annual meeting, Ramius is still entitled to recommend a replacement.

“We have agreed that our Nominating and Corporate Governance Committee will not unreasonably withhold acceptance of any replacement director recommended by the Ramius Group,” Analogic officials wrote in a December filing with the federal Securities and Exchange Commission.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: Analogic

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy